A Note from Dr Brett Glotzbecker - Chief Medical Officer, Seidman
Additional testing criteria for patients who have a history of a hematologic malignancy, undergone stem cell transplant or CAR-T cell therapy or patients with Sickle Cell disease.
New! Coronavirus (COVID-19) Questions and Answers
Read what's new - download the document!Covid 19
Inpatient Safety Policy Changes at CMC and Seidman Cancer Center
Updated Inpatient Safety Policy for UH Seidman Cancer Center and Cleveland Medical Center